
InvivoGen Therapeutics is comprised of an experienced team of scientists and business professionals eager to grow and develop this exciting new venture.
| Gérard TIRABY |
President and CEO of Cayla-InvivoGen
PhD in Microbiology, former Professor of Microbiology at the University Paul Sabatier (Toulouse, France)
|
| Daniel DROCOURT |
Chief Scientific Officer
PhD in Microbiology
25-year experience in molecular biology and gene therapy
|
| Jean-Paul REYNES |
Head of the Molecular Biology unit
PhD in Microbiology
25-year experience in molecular biology
|
| Gilles CAMBOIS |
Head of the GMP platform
Master of Science in Molecular and Cell Pharmacology
9-year experience in micro-organism Engineering and plasmid DNA purification
|
| Eric PEROUZEL |
Business Development Manager
PhD in Gene Therapy
Experience in International Business Development
|